Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 17/20 | 0.57 |
| ▸ | CTSD | P07339 | 1/20 | 0.53 |
| ▸ | BCHE | P06276 | 1/20 | 0.52 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL7031080 | 1.00 | BACE1 (0.57) | BACE1CTSDBCHEBACE2 | |
| SCHEMBL13409422 | 0.92 | BACE1 (0.57) | BACE1CTSDBACE2 | |
| SCHEMBL3355576 | 0.92 | BACE1 (0.57) | BACE1CTSDBACE2 | |
| SCHEMBL3349956 | 0.92 | BACE1 (0.57) | BACE1CTSDBACE2 | |
| Hydrochloric Acid SCHEMBL5221888 | 0.91 | BACE1 (0.56) | BACE1CTSDBACE2 | |
| SCHEMBL165644 | 0.85 | BCHE (0.61) | BACE1CTSDBCHE | |
| SCHEMBL4214871 | 0.85 | BCHE (0.61) | BACE1CTSDBCHE | |
| Hydrochloric Acid SCHEMBL5219257 | 0.85 | BACE1 (0.49) | BACE1CTSDBCHE | |
| Hydrochloric Acid SCHEMBL5348922 | 0.84 | BCHE (0.60) | BACE1CTSDBCHE | |
| Hydrochloric Acid SCHEMBL6110582 | 0.84 | BCHE (0.60) | BACE1CTSDBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040171881-A1 | N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives | PHARMACIA & UPJOHN COMPANY | 2004-09-02 | — | — | US | disclosed |
| US-20020128255-A1 | Compounds to treat alzheimer's disease | PHARMACIA & UPJOHN COMPANY | 2002-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128255-A1 | Compounds to treat alzheimer's disease | PSEN2, PSEN1, APP | BACE1 4/4885CTSD 2080/4885BCHE 12/4885 |
| US-20040171881-A1 | N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives | BACE1, BACE2, PSEN1 | BACE1 1/4885CTSD 249/4885BCHE 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.